These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 30894404)

  • 1. Human GPRC6A Mediates Testosterone-Induced Mitogen-Activated Protein Kinases and mTORC1 Signaling in Prostate Cancer Cells.
    Ye R; Pi M; Nooh MM; Bahout SW; Quarles LD
    Mol Pharmacol; 2019 May; 95(5):563-572. PubMed ID: 30894404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRISPR/Cas9 targeting of GPRC6A suppresses prostate cancer tumorigenesis in a human xenograft model.
    Ye R; Pi M; Cox JV; Nishimoto SK; Quarles LD
    J Exp Clin Cancer Res; 2017 Jun; 36(1):90. PubMed ID: 28659174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DRD3 (dopamine receptor D3) but not DRD2 activates autophagy through MTORC1 inhibition preserving protein synthesis.
    Barroso-Chinea P; Luis-Ravelo D; Fumagallo-Reading F; Castro-Hernandez J; Salas-Hernandez J; Rodriguez-Nuñez J; Febles-Casquero A; Cruz-Muros I; Afonso-Oramas D; Abreu-Gonzalez P; Moratalla R; Millan MJ; Gonzalez-Hernandez T
    Autophagy; 2020 Jul; 16(7):1279-1295. PubMed ID: 31538542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Humanized GPRC6A
    Pi M; Xu F; Ye R; Nishimoto SK; Kesterson RA; Williams RW; Lu L; Quarles LD
    Sci Rep; 2020 Jul; 10(1):11143. PubMed ID: 32636482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GPRC6A mediates the non-genomic effects of steroids.
    Pi M; Parrill AL; Quarles LD
    J Biol Chem; 2010 Dec; 285(51):39953-64. PubMed ID: 20947496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Signal transduction pathways in androgen-dependent and -independent prostate cancer cell proliferation.
    Ghosh PM; Malik SN; Bedolla RG; Wang Y; Mikhailova M; Prihoda TJ; Troyer DA; Kreisberg JI
    Endocr Relat Cancer; 2005 Mar; 12(1):119-34. PubMed ID: 15788644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Explaining Divergent Observations Regarding Osteocalcin/GPRC6A Endocrine Signaling.
    Pi M; Nishimoto SK; Darryl Quarles L
    Endocrinology; 2021 Apr; 162(4):. PubMed ID: 33474566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GPRC6A regulates prostate cancer progression.
    Pi M; Quarles LD
    Prostate; 2012 Mar; 72(4):399-409. PubMed ID: 21681779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The GST-BHMT assay reveals a distinct mechanism underlying proteasome inhibition-induced macroautophagy in mammalian cells.
    Rui YN; Xu Z; Chen Z; Zhang S
    Autophagy; 2015; 11(5):812-32. PubMed ID: 25984893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapamycin attenuates BAFF-extended proliferation and survival via disruption of mTORC1/2 signaling in normal and neoplastic B-lymphoid cells.
    Zeng Q; Qin S; Zhang H; Liu B; Qin J; Wang X; Zhang R; Liu C; Dong X; Zhang S; Huang S; Chen L
    J Cell Physiol; 2018 Jan; 233(1):516-529. PubMed ID: 28300280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IGF-1-stimulated protein synthesis in oligodendrocyte progenitors requires PI3K/mTOR/Akt and MEK/ERK pathways.
    Bibollet-Bahena O; Almazan G
    J Neurochem; 2009 Jun; 109(5):1440-51. PubMed ID: 19453943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of GPR30 inhibits the growth of prostate cancer cells through sustained activation of Erk1/2, c-jun/c-fos-dependent upregulation of p21, and induction of G(2) cell-cycle arrest.
    Chan QK; Lam HM; Ng CF; Lee AY; Chan ES; Ng HK; Ho SM; Lau KM
    Cell Death Differ; 2010 Sep; 17(9):1511-23. PubMed ID: 20203690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The PI3K/Akt and mTOR/P70S6K signaling pathways in human uveal melanoma cells: interaction with B-Raf/ERK.
    Babchia N; Calipel A; Mouriaux F; Faussat AM; Mascarelli F
    Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):421-9. PubMed ID: 19661225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteocalcin Induces Proliferation via Positive Activation of the PI3K/Akt, P38 MAPK Pathways and Promotes Differentiation Through Activation of the GPRC6A-ERK1/2 Pathway in C2C12 Myoblast Cells.
    Liu S; Gao F; Wen L; Ouyang M; Wang Y; Wang Q; Luo L; Jian Z
    Cell Physiol Biochem; 2017; 43(3):1100-1112. PubMed ID: 28977794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GPRC6A: Jack of all metabolism (or master of none).
    Pi M; Nishimoto SK; Quarles LD
    Mol Metab; 2017 Feb; 6(2):185-193. PubMed ID: 28180060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of Akt-mTOR, ubiquitin-proteasome and autophagy-lysosome pathways in response to formoterol administration in rat skeletal muscle.
    Joassard OR; Amirouche A; Gallot YS; Desgeorges MM; Castells J; Durieux AC; Berthon P; Freyssenet DG
    Int J Biochem Cell Biol; 2013 Nov; 45(11):2444-55. PubMed ID: 23916784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. L-arginine stimulates fibroblast proliferation through the GPRC6A-ERK1/2 and PI3K/Akt pathway.
    Fujiwara T; Kanazawa S; Ichibori R; Tanigawa T; Magome T; Shingaki K; Miyata S; Tohyama M; Hosokawa K
    PLoS One; 2014; 9(3):e92168. PubMed ID: 24651445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chrysin induces death of prostate cancer cells by inducing ROS and ER stress.
    Ryu S; Lim W; Bazer FW; Song G
    J Cell Physiol; 2017 Dec; 232(12):3786-3797. PubMed ID: 28213961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Remnant lipoproteins stimulate proliferation and activate MAPK and Akt signaling pathways via G protein-coupled receptor in PC-3 prostate cancer cells.
    Sekine Y; Koike H; Nakano T; Nakajima K; Suzuki K
    Clin Chim Acta; 2007 Aug; 383(1-2):78-84. PubMed ID: 17512923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Membrane androgen receptor characteristics of human ZIP9 (SLC39A) zinc transporter in prostate cancer cells: Androgen-specific activation and involvement of an inhibitory G protein in zinc and MAP kinase signaling.
    Thomas P; Pang Y; Dong J
    Mol Cell Endocrinol; 2017 May; 447():23-34. PubMed ID: 28219737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.